Serum Institue of India's Poonawalla expects Omicron-specific vaccine in six months
Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, reports ndtv.com on Monday.
SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield.
This is a breaking news story, more details will be added soon. Please keep refreshing this page.